As Trpc6 is widely expressed, including in mesangial cells, renal tubular epithelial cells, smooth muscle cells, and fibroblasts [13, 33–35], the relative importance of TRPC6 activity in podocytes versus other cells types in the pathogenesis of FSGS is unclear. This evidence concerns the gene TRPC6 and focal segmental glomerulosclerosis.